Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells.

Nørsett KG, Steele I, Duval C, Sammut SJ, Murugesan SV, Kenny S, Rainbow L, Dimaline R, Dockray GJ, Pritchard DM, Varro A.

Am J Physiol Gastrointest Liver Physiol. 2011 Sep;301(3):G446-53. doi: 10.1152/ajpgi.00527.2010. Epub 2010 Dec 30.

2.

Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells.

Kenny S, Duval C, Sammut SJ, Steele I, Pritchard DM, Atherton JC, Argent RH, Dimaline R, Dockray GJ, Varro A.

Am J Physiol Gastrointest Liver Physiol. 2008 Sep;295(3):G431-41. doi: 10.1152/ajpgi.90283.2008. Epub 2008 Jul 3.

3.

Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.

Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A.

J Hepatol. 1999 Oct;31(4):703-11.

PMID:
10551395
4.

The role of plasminogen activator inhibitor-1 in gastric mucosal protection.

Kenny S, Steele I, Lyons S, Moore AR, Murugesan SV, Tiszlavicz L, Dimaline R, Pritchard DM, Varro A, Dockray GJ.

Am J Physiol Gastrointest Liver Physiol. 2013 May 1;304(9):G814-22. doi: 10.1152/ajpgi.00017.2013. Epub 2013 Mar 14.

6.

Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.

Hong SI, Park IC, Son YS, Lee SH, Kim BG, Lee JI, Lee TW, Kook YH, Min YI, Hong WS.

J Korean Med Sci. 1996 Feb;11(1):33-7.

7.

Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.

Illemann M, Bird N, Majeed A, Laerum OD, Lund LR, Danø K, Nielsen BS.

Int J Cancer. 2009 Apr 15;124(8):1860-70. doi: 10.1002/ijc.24166.

8.
9.

Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.

Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY, Tang HB.

J Cancer Res Clin Oncol. 2000 Nov;126(11):641-6.

PMID:
11079728
10.

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.

Scand J Gastroenterol. 2005 Jul;40(7):783-93.

PMID:
16109653
11.

Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.

Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70.

PMID:
15790903
12.
13.

Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling.

Varro A, Kenny S, Hemers E, McCaig C, Przemeck S, Wang TC, Bodger K, Pritchard DM.

Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1133-40. Epub 2007 Jan 11.

14.

The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.

Shetty S, Padijnayayveetil J, Tucker T, Stankowska D, Idell S.

Am J Physiol Lung Cell Mol Physiol. 2008 Dec;295(6):L967-75. doi: 10.1152/ajplung.90349.2008. Epub 2008 Oct 3. Review.

15.

PAI-1 deficiency increases the trophic effects of hypergastrinemia in the gastric corpus mucosa.

Fossmark R, Rao S, Mjønes P, Munkvold B, Flatberg A, Varro A, Thommesen L, Nørsett KG.

Peptides. 2016 May;79:83-94. doi: 10.1016/j.peptides.2016.03.016. Epub 2016 Mar 30.

PMID:
27038741
16.

Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.

Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.

J Lab Clin Med. 2004 Aug;144(2):69-77.

PMID:
15322501
17.

Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.

Castelló R, Landete JM, España F, Vázquez C, Fuster C, Almenar SM, Ramón LA, Radtke KP, Estellés A.

Thromb Res. 2007;120(5):753-62. Epub 2007 Jan 29.

PMID:
17258797
18.

Identification of plasminogen activator inhibitor-2 as a gastrin-regulated gene: Role of Rho GTPase and menin.

Varro A, Hemers E, Archer D, Pagliocca A, Haigh C, Ahmed S, Dimaline R, Dockray GJ.

Gastroenterology. 2002 Jul;123(1):271-80.

PMID:
12105855
19.

Expression of urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer.

Kawasaki K, Hayashi Y, Wang Y, Suzuki S, Morita Y, Nakamura T, Narita K, Doe W, Itoh H, Kuroda Y.

J Gastroenterol Hepatol. 1998 Sep;13(9):936-44.

PMID:
9794194
20.

Supplemental Content

Support Center